Check out what's new in this month's newsletter
- Get your message in front of HCDMs with our new Spotlight offering
- Keep up on the latest developments with the AMCP dossier Format v5.0 resources
- Mark your calendars - we'll be at ThoughtSpot 2024 in July!
Get your message in front of HCDMs outside of the FormularyDecisions platform with a feature like this banner in our monthly FormularyDecisions Connection newsletter, which is sent to all of our HCDM users.
AMCP dossier Format v5.0 resources
Join our dossier experts for an informal snack-and-learn
The Cencora team has received many questions regarding the changes to the AMCP Format and how it will affect current and future dossiers. Our AMCP dossier experts are offering an informal 30-minute call to provide an overview of the key changes within AMCP Format v5.0 and answer any questions that you may have regarding this update.
We are also able to share insights into opportunities for new evidence generation and product differentiation with the new Format.
Interested in learning more? Connect with one of our dossier experts below:
Cencora webinar: Unlocking AMCP Format Version 5.0
Navigating updates and best practices for formulary dossiers
Watch this webinar on-demand today to learn about the latest AMCP Format Version 5.0 updates and best practices for formulary dossiers, featuring Adam Hoye-Simek, chair of the AMCP Format for Formulary Submissions Committee, and experts from the Cencora Evidence Generation and Value Communications, and Evidence Synthesis and Modeling teams.
This engaging webinar will kick off with a presentation covering key revisions in the AMCP Format 5.0, followed by an insightful panel discussion. Don’t miss this opportunity to refine your dossier submissions with expert guidance.
Moderator:
Jasmine Knight, PharmD, MS, Senior Director, Digital Solutions, CencoraPanelists:
- Adam Hoye-Simek, PharmD, RPH, Chair, Format for Formulary Submissions Committee, AMCP
- Ken O'Day, PhD, MPA, Senior Director, Evidence Synthesis & Modeling, Cencora
- Ben Penley, PharmD, MS, Manager, Evidence Generation & Value Communications, Cencora
- Kimberly Ruiz, EdM, Senior Director, Evidence Generation & Value Communications, Cencora
Learning objectives:
- Understanding of the updates and revisions in the latest AMCP Format Version 5.0
- Best practices for creating dossiers that align with the new AMCP Format guidance
- Effective approaches to economic modeling with dossier submissions
- Strategies for digital therapeutics, leveraging real-world evidence, addressing health disparities, and optimizing clinical evidence in dossier content
More information
See full AMCP Format v5.0 details at AMCP.org
New and Improved – AMCP Format for Formulary Submissions v5.0: Webinar recording
Payer pre-approval information needs and how manufacturers can better meet them: Read article and Download poster
Interested in learning more? Email one of our dossier experts.
July 24-27, Orlando, FL
ThoughtSpot 2024
Continuing education session
Old bugs, new tricks: the latest on vaccines, immunization schedules, and community health
Time: 4-5 PM ET
Each year, the healthcare system grapples with increased infections and hospitalizations that disproportionately affect vulnerable populations such as infants and adults over the age of 60. In light of the introduction of new preventive measures and vaccines, pharmacy professionals need to be equipped with background on their approved indications, clinical trial results, recent clinical guideline recommendations, and considerations for use. New evidence, including real-world data, can also signify methods and strategies for the implementation of vaccines in the evolving clinical landscape.
In this session, we explore the key differences between newly approved agents, their place in therapy based on 2024 immunization recommendations, and best practices for discussing vaccines in diverse community pharmacy settings. Given that vaccination rates can be affected by many factors, including cultural, social, and political influences, the session will incorporate interactive case studies to also address opportunities for overcoming vaccine fatigue and hesitancy.
Speakers:
- Nick Howard, PharmD, Health Outcomes & Market Access Fellow, Cencora
- Tasmina Hydery, PharmD, MBA, BCGP, Associate Director of Digital Solutions, Cencora
Pharmacist learning objectives:
- Summarize the clinical trial results and considerations for use of newly approved agents
- Review 2024 immunization schedules and recommendations based on expert consensus guidelines
- Review guidance for the administration of vaccines
- Apply strategies for discussing vaccines with patients in the pharmacy setting to improve overall community health outcomes
Not attending? Request a copy of the slides.
